Apimeds Pharmaceuticals US, Inc. (APUS)

Apimeds Pharmaceuticals US, Inc. has filed 119 documents with the SEC available on Filing Fan. Browse annual reports (10-K), quarterly reports (10-Q), earnings releases (8-K), proxy statements, and more on Filing Fan. Filing Fan provides income statements, balance sheets, cash flow statements, and segment data parsed directly from EDGAR filings. All financial data is sourced from publicly available SEC regulatory filings.

Recent SEC filings

Form Date Description
8-K 2026-07-13 Other Events; Financial Statements and Exhibits
10-Q 2026-05-26 Quarterly Report
NT 10-Q 2026-05-15 Notification of Late Filing (Quarterly)
SC 13D/A 2026-05-07 Beneficial Ownership Report (Amended)
8-K 2026-05-05 Departure/Appointment of Directors or Officers
10-K 2026-05-04 Annual Report
8-K 2026-05-04 Entry into a Material Definitive Agreement; Departure/Appointment of Directors or Officers
8-K 2026-04-22 Notice of Delisting or Transfer; Financial Statements and Exhibits
8-K 2026-04-16 Other Events
8-K/A 2026-04-09 Departure/Appointment of Directors or Officers; Amendments to Articles of Incorporation or Bylaws (Amended)